What’s new for psoriasis management in 2020? Treatment updates and COVID-19 concerns

+Practice

DERMATOLOGY

What’s new for psoriasis management in 2020? Treatment updates and COVID-19 concerns

3 June 2020

Louise Reiche

Wednesday 3 June 2020, 02:03 PM

Chronic plaque psoriasis on the elbow, a commonly affected site

A comprehensive review of the pathogenesis, diagnostic characteristics and available treatments for psoriasis was outlined in a previous How to Treat (New Zealand Doctor, 13 February 2019). This article expands on changes in therapies since then

Key points, A new foam spray formulation of calcipotriol/betamethasone is now available in New Zealand for psoriasis management. Biologics have proven superior , Pract Green w Pale Yellow

COVID-19

Dermatology

Medicines and Therapies

References

Reiche L. How to treat psoriasis. New Zealand Doctor. 13 February 2019.
Paul C, Bang B, Lebwohl M. Fixed combination calcipotriol plus betamethasone dipropionate aerosol foam in the treatment of psoriasis vulgaris: rationale for development and clinical profile. Expert Opin Pharmacother 2017;18(1):115–21.
LEO Pharma Ltd. New Zealand Data Sheet: Enstilar. April 2020. www.medsafe.govt.nz
Gerdes S, Krakor M, Anger T, et al. Prospective, observational, non-interventional, multicentre study on the efficacy and tolerability of a new calcipotriol/betamethasone aerosol foam (Enstilar®) in patients with plaque psoriasis under daily practice conditions. Dermatology 2017;233(6):425–34.
Sbidian E, Chaimani A, Afach S, et al. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst Rev 2020;1(1):CD011535.
Kamata M, Tada Y. Efficacy and safety of biologics for psoriasis and psoriatic arthritis and their impact on comorbidities: A literature review. Int J Mol Sci 2020;21(5):1690.
Kamata M, Tada Y. Safety of biologics in psoriasis. J Dermatol 2018;45(3):279–86.
Rademaker M, Baker C, Foley P, et al. Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases. Australas J Dermatol 2020;61(2):158–59.

How to Treat

Prostate cancer

Prostate cancer consultations are common in primary care and there is no one approach to testing and treatment that fits all patients. Urologist Simon van Rij discusses the key considerations and options for personalised care, appropriate investigation and treatment

Wednesday 11 September 2024, 12:45 AM